US20190183601A1 - Target identification tool for intra-body localization - Google Patents

Target identification tool for intra-body localization Download PDF

Info

Publication number
US20190183601A1
US20190183601A1 US16/281,564 US201916281564A US2019183601A1 US 20190183601 A1 US20190183601 A1 US 20190183601A1 US 201916281564 A US201916281564 A US 201916281564A US 2019183601 A1 US2019183601 A1 US 2019183601A1
Authority
US
United States
Prior art keywords
body portion
identification device
sharpened
tissue
longitudinal axis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US16/281,564
Inventor
Shai Fitelzon
Paige B. Hastings
David J. McKinley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rioja LLC
Covidien LP
Original Assignee
Covidien LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Covidien LP filed Critical Covidien LP
Priority to US16/281,564 priority Critical patent/US20190183601A1/en
Assigned to SUPERDIMENSION, LTD. reassignment SUPERDIMENSION, LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HASTINGS, PAIGE B., FITELZON, SHAI, MCKINLEY, DAVID J.
Assigned to SUPERDIMENSION, INC. reassignment SUPERDIMENSION, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SUPERDIMENSION, LTD.
Assigned to RIOJA LLC reassignment RIOJA LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SUPERDIMENSION, INC.
Assigned to COVIDIEN LP reassignment COVIDIEN LP ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: RIOJA LLC
Publication of US20190183601A1 publication Critical patent/US20190183601A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00889Material properties antimicrobial, disinfectant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00893Material properties pharmaceutically effective
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00942Material properties hydrophilic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3904Markers, e.g. radio-opaque or breast lesions markers specially adapted for marking specified tissue
    • A61B2090/3908Soft tissue, e.g. breast tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3904Markers, e.g. radio-opaque or breast lesions markers specially adapted for marking specified tissue
    • A61B2090/3912Body cavities
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/392Radioactive markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3937Visible markers
    • A61B2090/3945Active visible markers, e.g. light emitting diodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3966Radiopaque markers visible in an X-ray image
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/397Markers, e.g. radio-opaque or breast lesions markers electromagnetic other than visible, e.g. microwave
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/397Markers, e.g. radio-opaque or breast lesions markers electromagnetic other than visible, e.g. microwave
    • A61B2090/3975Markers, e.g. radio-opaque or breast lesions markers electromagnetic other than visible, e.g. microwave active
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3987Applicators for implanting markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3991Markers, e.g. radio-opaque or breast lesions markers having specific anchoring means to fixate the marker to the tissue, e.g. hooks

Definitions

  • VATS Video Assisted Thoracotomy Surgery
  • Obtaining accurate diagnosis in the least invasive means possible as quickly as possible is essential.
  • VATS it is often very hard to recognize the suspected small lung masses during the procedure.
  • VATS success is limited by the ability to visualize and palpate the nodule if it is less than 10 mm in size and if it is more than 5 mm from a pleural surface. Historically, in 63% to 82% of cases there is an inability to visualize or palpate a detected nodule.
  • a lung mass (solitary pulmonary nodules (SPN) or other) in the periphery of the lungs that is identified by X-ray machine or CT must also be physically identified by the surgeon for removal.
  • visual identification of the mass may often be difficult due to tissue obstructions, such as, when the nodule is buried deep in the lung tissue.
  • Most current methods for identifying masses and other such lesions and tissues may best be characterized as “from the outside to the inside,” and are often rather complex, invasive and risky.
  • Such methods include, for example, manual identification (e.g., finger palpation through the rib cage), intrathorascopic ultrasound, transthoracic placement of an external wire, injecting solidifying liquids, dye injection, TC-99 injection, radiopaque markers such as barium or injectable coils, guidance by CT, intrathorascopic ultrasound, fluoroscopy-assisted thoracoscopic resection, etc.
  • Another potential application for marker or catheter placement within the lungs may be for the delivery of therapies such as brachytherapy, cryotherapy, or drug delivery through a deposited drug depot.
  • an identification device or marking device that: 1) can be placed within the location of interest or adjacent to it and permits identification of masses or other location of interest, through the surrounding tissues, 2) is minimally invasive, and 3) has a minimal damaging effect on the tissue to avoid complications.
  • the first is the so called identification device or marking device and the second is the complementary counterpart, which is an assembly of detector device and interventional device, capable to identify the signal emitted by the identification device or marking device, thus, the precision in localization is achieved and the task can be performed with great confidence.
  • one aspect of the present invention is to provide an identification or marking device and method that overcomes the limitations of the prior art.
  • Another aspect of the present invention is to provide an identification or therapeutic device that may be placed permanently or semi-permanently (removable only with excision of the surrounding tissue) or removably (without significant trauma to the surrounding tissue).
  • Another aspect of the present invention is to provide an identification or therapeutic device that may be pre-, intra- or post operatively activated and implanted in the location of interest or adjacent to the location of interest within the body (for example, at or near a mass and surrounding tissues desired for extraction).
  • Another aspect of the present invention is to provide a body portion of the identification device that will be sufficiently illuminating to be seen through adjacent tissues and/or sufficient to indicate the exact location of interest by visualization of the light via the naked eye and/or through any kind of endoscope and/or sufficient to indicate the exact location of interest by sound, ultrasound, radioactive material electromagnetic emitting device or other form of energy.
  • Another aspect of the present invention is to provide a complementing counterpart, which is a permanent assembly or add-on detector device, coupled to an interventional device (e.g. light endoscope, Geiger meter), and capable of identifying the signal emitted by the identification device or marking device and communicating its location to the user.
  • an interventional device e.g. light endoscope, Geiger meter
  • Yet another aspect of the invention provides various anchoring devices that prevent the markers or therapeutic seeds of the present invention from migrating once implanted.
  • FIG. 1 is a side view of an embodiment of the device of present invention
  • FIG. 1 a is a side view of an embodiment of the device of the present invention.
  • FIG. 2 is a side view of the embodiment of the device of FIG. 1 implanted into body tissue;
  • FIG. 3 is a perspective view of an embodiment of the device of the present invention.
  • FIG. 4 is a perspective view of the embodiment of the device of FIG. 3 implanted into body tissue;
  • FIG. 5 is a perspective view of an embodiment of the device of the present invention.
  • FIG. 6 is a perspective view of the embodiment of the device of FIG. 5 implanted into body tissue
  • FIG. 7 is a perspective view of an embodiment of the device of the present invention.
  • FIG. 8 is an end view of the embodiment of the device of FIG. 7 of the present invention.
  • FIG. 9 is a side view of an embodiment of the device of the present invention.
  • FIG. 10 is an end view of the embodiment of the device of FIG. 9 ;
  • FIG. 11 is a perspective view of an embodiment of the device of the present invention being injected into body tissue
  • FIG. 12 is a side view of the embodiment of the device of FIG. 11 implanted in tissue;
  • FIG. 13 is a side elevation of an embodiment of the device of the present invention.
  • FIGS. 14 and 15 are side elevations of the device of FIG. 13 being implanted into tissue.
  • the present invention includes an identification or therapeutic device comprising a body portion and an anchoring portion, which is introducible into an intra-body structure (e.g., a mass or lesion) and/or an anatomical space to mark a location of interest (e.g., a tissue layer and/or lumen of a body cavity).
  • the identification device of the present invention may include a power source, either external to the body or internally at or near the body portion or some combination thereof. It is understood that any of the various anchoring portions described below may be used with any of the body portions. It is also understood that the body portions may give off energy, such as light energy (i.e. glow-in-the-dark materials, LEDs, incandescent devices, etc.), thermal energy, radiation, RF energy, acoustic energy, or cryoenergy.
  • light energy i.e. glow-in-the-dark materials, LEDs, incandescent devices, etc.
  • thermal energy i.e. glow-in-the-dark materials, LEDs
  • the various embodiments of the body portions may be constructed of various application-specific materials.
  • the body portions may be loaded with chemicals or dyes that enhance localization.
  • Non-limiting examples include: BaSO4, bismuth, copper, gold, and platinum.
  • the body portions could be loaded with drugs and/or chemotherapy agents for treatment and have features such as controlled elution and diffusion rates.
  • Non-limiting examples of these agents include antineoplastics, antiobiotics and others.
  • FIGS. 1, 1 a , and 2 illustrate an identification or therapeutic device 10 , including a body portion 12 and anchoring portion 14 .
  • the body portion 12 may be any energy source or simply a marker or a focusing element for RF energy, as described above. If an energy source is used, it is understood that appropriate additional equipment will be used in order to receive and identify the energy being transmitted.
  • the body portion 12 may also comprise a hollow body in the event that the device 10 is implanted in an airway.
  • the anchoring portion 14 is shaped and oriented to render it introducible into or adjacent to an intra-body structure.
  • the anchoring portion 14 may also include hooks or barbs 15 , to improve the anchoring ability of the anchoring portion 14 .
  • the barbs 15 are small enough to allow removal with minimal tissue damage.
  • the anchoring portion of the identification or therapeutic device 10 is inserted into an intra-body structure (e.g., a tissue layer) 16 .
  • the anchoring portion 14 leaves the body portion 12 oriented adjacent to the tissue layer 16 , providing fixed, yet removable illumination or therapy.
  • the device 10 may be pulled out of the tissue layer and removed from the body or the tissue may be excised with the identification device 10 still affixed thereto.
  • an identification or therapeutic device 20 includes a body portion 12 and at least one anchoring mechanism 24 .
  • the anchoring portion 24 is one or more barbed rings encircling the device 20 .
  • the barbs on the rings may be evenly spaced around the device 20 , thereby providing ease of implantation as orientation-specific deployment is not necessary.
  • the barbs are strong enough to penetrate tissue yet flexible enough to lay flat in a deployment catheter. If the device 20 is intended to be non-permanent, the barbs should be short and flexible enough to allow removal without excessive tissue damage.
  • FIG. 4 illustrates the device 20 inserted into an adjacent tissue layer 26 via the at least one anchoring mechanism 24 .
  • an identification or therapeutic device 30 includes a body portion 12 and an anchoring portion 34 .
  • the anchoring portion 34 includes, for example, a mesh and/or tissue adhesive affixed on at least a portion of the surface of the body portion 12 .
  • the mesh may be bioreactive.
  • the anchoring portion 34 adheres to a tissue layer 36 .
  • the anchoring portion 34 is large enough to connect with the tissue layer 36 , such that it will remain attached until some amount of applied force is used to remove the identification device 30 from the tissue layer 36 .
  • FIG. 6 illustrates the identification device 30 affixed to a tissue layer 36 .
  • an identification or therapeutic device 40 includes a body portion 12 and an anchoring portion 44 .
  • the anchoring portion 44 is disposed within a body lumen and may or may not penetrate the surrounding tissue layer 46 .
  • One example of the anchoring portion 44 contemplated for use in this embodiment of the invention would include a coil or stent 44 with a body portion 12 attached to an inside surface of the stent 44 .
  • the anchoring portion 44 expands, either via balloon or self-expanding design, to fit the surrounding tissue layer 46 .
  • the anchoring portion 44 is deliverable by any known or unknown methods.
  • the anchoring portion 44 may be collapsed to fit in or around a delivery catheter (not shown) and delivered and expanded in a desire location.
  • an identification or therapeutic device 50 includes a body portion 12 and an anchoring portion 54 .
  • the anchoring portion 52 is a staple that connects the device 50 to a tissue layer 56 . Removal of the identification device 50 may occur via excision of all or part of the surrounding tissue layer 56 .
  • the identification devices described above may be introduced and placed into the body by various delivery devices and methods.
  • Such delivery devices and methods may include, alone or in combination, use of catheters, guiding catheters, guide wires, stents, balloons, needles, bronchoscopy procedures and tools and/or the superDimension localization system, as described in U.S. patent application Ser. No. 11/571,796 filed on Jan. 8, 2007, which is incorporated by reference herein in its entirety.
  • deliveries may be made into branches of the lungs, blood vessels and other points of interest (body cavities, lumens).
  • FIGS. 11 and 12 For example, one embodiment of a device 60 of the present invention that is injected into tissue is shown in FIGS. 11 and 12 .
  • the identification device 60 includes a body portion 12 that is injected into a tissue layer 64 .
  • the surrounding tissue layer 64 may effectively hold the identification device 60 in place.
  • an additional anchoring portion may be added, such as any of the above described anchoring portions or merely a rough surface to prevent migration.
  • FIG. 11 illustrates a needle 66 containing an identification or therapeutic device 60 prior to delivery into a tissue layer 64 .
  • FIG. 12 illustrates the placement of the identification device 60 within the tissue layer 64 , post-injection.
  • FIGS. 13-15 illustrate an embodiment of a device 70 of the present invention that is specifically designed to be injected into tissue.
  • the device includes a capsule 74 surrounding the body portion 72 to allow the device 70 to be smoothly injected into tissue 78 . Once in contact with the tissue, the capsule 74 quickly dissolves, allowing the tissue 78 to close in around the body portion 72 .
  • the body portion 72 includes one or more anchoring features 76 , such as ridges, spikes, rough surfaces, barbs, or other shapes or mechanisms that would prevent the device 70 from migrating.
  • the capsule 74 is smooth such that minimal tissue trauma occurs during insertion.
  • the capsule may be constructed, for example, of a quickly dissolving material such as many water-soluble polymers.
  • Another embodiment of the present invention includes a device that is specifically designed to be injected into the target location for external localization.
  • the entire device may be dissolvable or biodegradable thus eliminating the necessity for removal.
  • the biodegradable material may be impregnated with a material such as metallic particles specifically selected to for image-guidance. The rate of degradation could be dependent on a known therapeutic dose to control or affect the targeted disease tissue.
  • biodegradable polymers polymers include, but are not limited to: PEVA poly(ethyl-vinyl-acetate), PBMA poly(butyl-methylacrylate), PLGA poly(lactic-glycolic acid), PLA (Polylactide), PLGA/PLA combination, HA (hydroxyapetite), PLGA-PEG (polyethylene glycol), Tyrosine derivatives, Polyanhydrides, Polyorthoesters, PBMA, DLPLA—poly(dl-lactide), LPLA—poly(l-lactide), PGA—polyglycolide, PDO—poly(dioxanone), PGA-TMC—poly(glycolide-co-trimethylene carbonate), PGA-LPLA—poly(l-lactide-co-glycolide), PGA-DLPLA—poly(dl-lactide-co-glycolide), LPLA-DLPLA—poly(l-lactide-co-
  • the above-described needle and syringe or plunger arrangement could be used to deliver an identification or therapeutic device internally, injecting said tool directly into a tissue layer from within the body cavity.
  • a needle of sufficient construction both to penetrate the chest cavity (e.g., between the ribs of a patient) and accommodate the dimensions of an identification or therapeutic device such that can be injected from outside a patient's body into a desired location (e.g., directly into surrounding tissues near a body cavity; into a fibroid or tumor that is intended to be excised from the body; etc).
  • the identification device could be delivered via a bronchoscope having a catheter attached therethrough which is advanced through the lungs of a patient to a point of interest.
  • the catheter will be equipped to push the identification device into a lumen of a body cavity near a tissue layer or into a tissue layer.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Surgical Instruments (AREA)

Abstract

A marker device that aids in the subsequent identification of a particular area is equipped with an anchoring device that prevents migration once placed in the tissue of that particular area. The device may include a chemical agent or drug that adds a therapeutic function to the marker device.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. patent application Ser. No. 15/194,667, filed Jun. 28, 2016, which is a continuation of U.S. patent application Ser. No. 12/362,421, filed Jan. 29, 2009, now U.S. Pat. No. 9,375,287, which claims the benefit of the filing date of provisional U.S. Patent Application No. 61/062,914, filed Jan. 29, 2008, and provisional U.S. Patent Application No. 61/051,632, filed May 8, 2008, the entire contents of each of which are incorporated herein by reference.
  • BACKGROUND
  • In the case of a suspected lung mass in a high risk patient for lung cancer, it is the current standard of care to send the patient for radical removal of the mass. Certain portions of these surgeries are made by Video Assisted Thoracotomy Surgery (VATS), which is a minimally invasive surgery, and invasive Thoracic Surgery. Obtaining accurate diagnosis in the least invasive means possible as quickly as possible is essential. During VATS, it is often very hard to recognize the suspected small lung masses during the procedure. VATS success is limited by the ability to visualize and palpate the nodule if it is less than 10 mm in size and if it is more than 5 mm from a pleural surface. Historically, in 63% to 82% of cases there is an inability to visualize or palpate a detected nodule. (1. Burdine, et al. CHEST 2002; 122:1467, 2. Suzuki, et al. CHEST 1999; 115:563). Minimally invasive surgery is becoming more and more popular and holds similar challenges to those seen in VATS when used in the abdominal cavity, the urogenital system or other parts of the body.
  • A lung mass (solitary pulmonary nodules (SPN) or other) in the periphery of the lungs that is identified by X-ray machine or CT must also be physically identified by the surgeon for removal. However, visual identification of the mass may often be difficult due to tissue obstructions, such as, when the nodule is buried deep in the lung tissue.
  • Lack of visual identification creates problems. In some instances, surgeons discover lesions during surgery that were not earlier identified by a referring physician or radiologist. In this case, the surgeon needs to decide which of the lesions is suspected to be cancerous. Therefore, to avoid mistakes, the surgeon typically removes a larger portion of the tissue, ensuring the entire lesion is removed but also increasing tissue trauma, the possibility of complications, patient suffering, and so forth. In other cases, lack of visual identification results in the excision of healthy tissue rather than the targeted lesion.
  • In other body cavities similar challenges are encountered since visibility and the means to identify specific pre-planned lesions as were identified by medical imaging, is often limited.
  • Most current methods for identifying masses and other such lesions and tissues may best be characterized as “from the outside to the inside,” and are often rather complex, invasive and risky. Such methods include, for example, manual identification (e.g., finger palpation through the rib cage), intrathorascopic ultrasound, transthoracic placement of an external wire, injecting solidifying liquids, dye injection, TC-99 injection, radiopaque markers such as barium or injectable coils, guidance by CT, intrathorascopic ultrasound, fluoroscopy-assisted thoracoscopic resection, etc.
  • There are current challenges with external beam radiation delivery due to the inability to see the tumor during treatment. Accurate alignment of sterotactic planning onto the patient, before the procedure, is required for accurate real-time tracking of the tumor. Additionally, tumor position in the lungs is changing as a result of the normal respiratory cycle, unpredictable baseline shifts and variable amplitude of respiratory rates. Consequently, an insufficient dose of radiation may be delivered due to its toxic effects on surrounding healthy lung tissue and may lead to failure to control tumor growth. Because of these challenges, fiducial markers are often used in soft tissue to guide focused-beam radiation treatment.
  • One of the major drawbacks to fiducial marker placement is delivery of the marker transthoracically. This approach can lead to pneumothorax or collapsed lungs because often the patients already have compromised lung function. In addition to the risk of pneumothorax there is also the complication of marker migration. Unlike the relatively static, homogeneous tissue of the prostate, the lung tissue moves significantly with the breathing cycle and is also porous and interlaced with airways. As a result, an implanted seed is prone to migrate, typically out of the channel formed during placement, and fall down an airway. Once in the airway, the seed will either settle in a distal portion of the lungs, or be coughed out.
  • Another potential application for marker or catheter placement within the lungs may be for the delivery of therapies such as brachytherapy, cryotherapy, or drug delivery through a deposited drug depot.
  • If an inert or active marker seed or temporary catheter migrates, the target is lost. If the therapy vehicle is expectorated, the treatment ends prematurely. Even worse, if the delivery vehicle migrates away from the target, therapy is administered to healthy tissue instead of a tumor, thereby damaging the healthy tissue and sparing the tumor.
  • There is a need for an improved identification device or marking device and method of introducing this device into the body. More specifically, there is a need for an identification device or marking device that: 1) can be placed within the location of interest or adjacent to it and permits identification of masses or other location of interest, through the surrounding tissues, 2) is minimally invasive, and 3) has a minimal damaging effect on the tissue to avoid complications.
  • There may also be a need for a method of extracting this device from the body in a minimally invasive manner.
  • There is also a need for anchoring an identification or therapeutic device or marking device within the body.
  • There is also a need for a method of communication or bringing between two tools, one from “inside out” and the other one from “outside in”. The first is the so called identification device or marking device and the second is the complementary counterpart, which is an assembly of detector device and interventional device, capable to identify the signal emitted by the identification device or marking device, thus, the precision in localization is achieved and the task can be performed with great confidence.
  • There is also a need for a marker or therapeutic seed that includes an anchoring mechanism that prevents the seed from migrating once positioned.
  • SUMMARY
  • In view of the foregoing, one aspect of the present invention is to provide an identification or marking device and method that overcomes the limitations of the prior art.
  • Another aspect of the present invention is to provide an identification or therapeutic device that may be placed permanently or semi-permanently (removable only with excision of the surrounding tissue) or removably (without significant trauma to the surrounding tissue).
  • Another aspect of the present invention is to provide an identification or therapeutic device that may be pre-, intra- or post operatively activated and implanted in the location of interest or adjacent to the location of interest within the body (for example, at or near a mass and surrounding tissues desired for extraction).
  • Another aspect of the present invention is to provide a body portion of the identification device that will be sufficiently illuminating to be seen through adjacent tissues and/or sufficient to indicate the exact location of interest by visualization of the light via the naked eye and/or through any kind of endoscope and/or sufficient to indicate the exact location of interest by sound, ultrasound, radioactive material electromagnetic emitting device or other form of energy.
  • Another aspect of the present invention is to provide a complementing counterpart, which is a permanent assembly or add-on detector device, coupled to an interventional device (e.g. light endoscope, Geiger meter), and capable of identifying the signal emitted by the identification device or marking device and communicating its location to the user.
  • Yet another aspect of the invention provides various anchoring devices that prevent the markers or therapeutic seeds of the present invention from migrating once implanted.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a side view of an embodiment of the device of present invention;
  • FIG. 1a is a side view of an embodiment of the device of the present invention;
  • FIG. 2 is a side view of the embodiment of the device of FIG. 1 implanted into body tissue;
  • FIG. 3 is a perspective view of an embodiment of the device of the present invention;
  • FIG. 4 is a perspective view of the embodiment of the device of FIG. 3 implanted into body tissue;
  • FIG. 5 is a perspective view of an embodiment of the device of the present invention;
  • FIG. 6 is a perspective view of the embodiment of the device of FIG. 5 implanted into body tissue;
  • FIG. 7 is a perspective view of an embodiment of the device of the present invention;
  • FIG. 8 is an end view of the embodiment of the device of FIG. 7 of the present invention;
  • FIG. 9 is a side view of an embodiment of the device of the present invention;
  • FIG. 10 is an end view of the embodiment of the device of FIG. 9;
  • FIG. 11 is a perspective view of an embodiment of the device of the present invention being injected into body tissue;
  • FIG. 12 is a side view of the embodiment of the device of FIG. 11 implanted in tissue;
  • FIG. 13 is a side elevation of an embodiment of the device of the present invention; and,
  • FIGS. 14 and 15 are side elevations of the device of FIG. 13 being implanted into tissue.
  • DETAILED DESCRIPTION
  • In general, the present invention includes an identification or therapeutic device comprising a body portion and an anchoring portion, which is introducible into an intra-body structure (e.g., a mass or lesion) and/or an anatomical space to mark a location of interest (e.g., a tissue layer and/or lumen of a body cavity). The identification device of the present invention may include a power source, either external to the body or internally at or near the body portion or some combination thereof. It is understood that any of the various anchoring portions described below may be used with any of the body portions. It is also understood that the body portions may give off energy, such as light energy (i.e. glow-in-the-dark materials, LEDs, incandescent devices, etc.), thermal energy, radiation, RF energy, acoustic energy, or cryoenergy.
  • Furthermore, the various embodiments of the body portions may be constructed of various application-specific materials. For example, the body portions may be loaded with chemicals or dyes that enhance localization. Non-limiting examples include: BaSO4, bismuth, copper, gold, and platinum. Also, the body portions could be loaded with drugs and/or chemotherapy agents for treatment and have features such as controlled elution and diffusion rates. Non-limiting examples of these agents include antineoplastics, antiobiotics and others.
  • One embodiment of the present invention is shown in FIGS. 1, 1 a, and 2 which illustrate an identification or therapeutic device 10, including a body portion 12 and anchoring portion 14. The body portion 12 may be any energy source or simply a marker or a focusing element for RF energy, as described above. If an energy source is used, it is understood that appropriate additional equipment will be used in order to receive and identify the energy being transmitted. The body portion 12 may also comprise a hollow body in the event that the device 10 is implanted in an airway.
  • The anchoring portion 14 is shaped and oriented to render it introducible into or adjacent to an intra-body structure. The anchoring portion 14, may also include hooks or barbs 15, to improve the anchoring ability of the anchoring portion 14. Preferably, the barbs 15 are small enough to allow removal with minimal tissue damage. As shown in FIG. 2, the anchoring portion of the identification or therapeutic device 10 is inserted into an intra-body structure (e.g., a tissue layer) 16. The anchoring portion 14 leaves the body portion 12 oriented adjacent to the tissue layer 16, providing fixed, yet removable illumination or therapy. (“Illumination” is being used in a general sense to include acoustic energy, radioactive energy, electromagnetic energy or other form of energy and should not be construed as being limited to casting visible light on a subject.) In this illustration of the embodiment, the device 10 may be pulled out of the tissue layer and removed from the body or the tissue may be excised with the identification device 10 still affixed thereto.
  • Another embodiment of the present invention is shown in FIG. 3, in which an identification or therapeutic device 20 includes a body portion 12 and at least one anchoring mechanism 24. The anchoring portion 24 is one or more barbed rings encircling the device 20. The barbs on the rings may be evenly spaced around the device 20, thereby providing ease of implantation as orientation-specific deployment is not necessary. Preferably, the barbs are strong enough to penetrate tissue yet flexible enough to lay flat in a deployment catheter. If the device 20 is intended to be non-permanent, the barbs should be short and flexible enough to allow removal without excessive tissue damage. FIG. 4 illustrates the device 20 inserted into an adjacent tissue layer 26 via the at least one anchoring mechanism 24.
  • Yet another embodiment of the present invention is shown in FIG. 5, in which an identification or therapeutic device 30 includes a body portion 12 and an anchoring portion 34. The anchoring portion 34 includes, for example, a mesh and/or tissue adhesive affixed on at least a portion of the surface of the body portion 12. The mesh may be bioreactive. The anchoring portion 34 adheres to a tissue layer 36. The anchoring portion 34 is large enough to connect with the tissue layer 36, such that it will remain attached until some amount of applied force is used to remove the identification device 30 from the tissue layer 36. FIG. 6 illustrates the identification device 30 affixed to a tissue layer 36.
  • Another embodiment of the present invention is shown in FIGS. 7 and 8, in which an identification or therapeutic device 40 includes a body portion 12 and an anchoring portion 44. In this embodiment, the anchoring portion 44 is disposed within a body lumen and may or may not penetrate the surrounding tissue layer 46. One example of the anchoring portion 44 contemplated for use in this embodiment of the invention would include a coil or stent 44 with a body portion 12 attached to an inside surface of the stent 44. The anchoring portion 44 expands, either via balloon or self-expanding design, to fit the surrounding tissue layer 46. The anchoring portion 44 is deliverable by any known or unknown methods. For example, the anchoring portion 44 may be collapsed to fit in or around a delivery catheter (not shown) and delivered and expanded in a desire location.
  • Another embodiment of the present invention is shown in FIGS. 9 and 10, in which an identification or therapeutic device 50 includes a body portion 12 and an anchoring portion 54. In this embodiment, the anchoring portion 52 is a staple that connects the device 50 to a tissue layer 56. Removal of the identification device 50 may occur via excision of all or part of the surrounding tissue layer 56.
  • The identification devices described above may be introduced and placed into the body by various delivery devices and methods. Such delivery devices and methods may include, alone or in combination, use of catheters, guiding catheters, guide wires, stents, balloons, needles, bronchoscopy procedures and tools and/or the superDimension localization system, as described in U.S. patent application Ser. No. 11/571,796 filed on Jan. 8, 2007, which is incorporated by reference herein in its entirety. In particular, such deliveries may be made into branches of the lungs, blood vessels and other points of interest (body cavities, lumens).
  • For example, one embodiment of a device 60 of the present invention that is injected into tissue is shown in FIGS. 11 and 12. The identification device 60 includes a body portion 12 that is injected into a tissue layer 64. The surrounding tissue layer 64 may effectively hold the identification device 60 in place. However, an additional anchoring portion may be added, such as any of the above described anchoring portions or merely a rough surface to prevent migration. FIG. 11 illustrates a needle 66 containing an identification or therapeutic device 60 prior to delivery into a tissue layer 64. FIG. 12 illustrates the placement of the identification device 60 within the tissue layer 64, post-injection.
  • FIGS. 13-15 illustrate an embodiment of a device 70 of the present invention that is specifically designed to be injected into tissue. The device includes a capsule 74 surrounding the body portion 72 to allow the device 70 to be smoothly injected into tissue 78. Once in contact with the tissue, the capsule 74 quickly dissolves, allowing the tissue 78 to close in around the body portion 72. Preferably, the body portion 72 includes one or more anchoring features 76, such as ridges, spikes, rough surfaces, barbs, or other shapes or mechanisms that would prevent the device 70 from migrating.
  • The capsule 74 is smooth such that minimal tissue trauma occurs during insertion. The capsule may be constructed, for example, of a quickly dissolving material such as many water-soluble polymers.
  • Another embodiment of the present invention includes a device that is specifically designed to be injected into the target location for external localization. The entire device may be dissolvable or biodegradable thus eliminating the necessity for removal. The biodegradable material may be impregnated with a material such as metallic particles specifically selected to for image-guidance. The rate of degradation could be dependent on a known therapeutic dose to control or affect the targeted disease tissue. Examples of some biodegradable polymers polymers include, but are not limited to: PEVA poly(ethyl-vinyl-acetate), PBMA poly(butyl-methylacrylate), PLGA poly(lactic-glycolic acid), PLA (Polylactide), PLGA/PLA combination, HA (hydroxyapetite), PLGA-PEG (polyethylene glycol), Tyrosine derivatives, Polyanhydrides, Polyorthoesters, PBMA, DLPLA—poly(dl-lactide), LPLA—poly(l-lactide), PGA—polyglycolide, PDO—poly(dioxanone), PGA-TMC—poly(glycolide-co-trimethylene carbonate), PGA-LPLA—poly(l-lactide-co-glycolide), PGA-DLPLA—poly(dl-lactide-co-glycolide), LPLA-DLPLA—poly(l-lactide-co-dl-lactide), PDO-PGA-TMC—poly(glycolide-co-trimethylene carbonate-co-dioxanone). Examples of metallic or other image-guidance materials include but are not limited to: radiopaque dyes or contrast agents such as BaSO4 or Ominpaque, metallic particles such as copper or gold particles.
  • Although the invention has been described in terms of particular embodiments and applications, one of ordinary skill in the art, in light of this teaching, can generate additional embodiments and modifications without departing from the spirit of or exceeding the scope of the claimed invention.
  • For example, the above-described needle and syringe or plunger arrangement could be used to deliver an identification or therapeutic device internally, injecting said tool directly into a tissue layer from within the body cavity. Alternatively, a needle of sufficient construction both to penetrate the chest cavity (e.g., between the ribs of a patient) and accommodate the dimensions of an identification or therapeutic device such that can be injected from outside a patient's body into a desired location (e.g., directly into surrounding tissues near a body cavity; into a fibroid or tumor that is intended to be excised from the body; etc).
  • The identification device could be delivered via a bronchoscope having a catheter attached therethrough which is advanced through the lungs of a patient to a point of interest. The catheter will be equipped to push the identification device into a lumen of a body cavity near a tissue layer or into a tissue layer.
  • Accordingly, it is to be understood that the drawings and descriptions herein are proffered by way of example to facilitate comprehension of the invention and should not be construed to limit the scope thereof.

Claims (21)

1. (canceled)
2. An identification device, comprising:
a body portion configured to mark a location in a patient's body; and
an anchoring portion coupled to an outer surface of the body portion and disposed axially around a longitudinal axis defined by the body portion, the anchoring portion having a plurality of sharpened portions extending in a first direction and configured to be inserted into tissue upon movement of the body portion in the first direction to removably anchor the body portion to the tissue.
3. The identification device according to claim 2, wherein the anchoring portion comprises a plurality of rings encircling the body portion and longitudinally spaced from each other along the longitudinal axis.
4. The identification device according to claim 3, wherein each of the plurality of sharpened portions of one of the plurality of rings is collinear with a respective one of the plurality of sharpened portions of another of the plurality of rings along the longitudinal axis defined by the body portion.
5. The identification device according to claim 2, wherein the body portion extends between a closed proximal end and a closed distal end.
6. The identification device according to claim 2, wherein the body portion extends between a rounded proximal end and a rounded distal end.
7. The identification device according to claim 2, wherein the plurality of sharpened portions are evenly spaced around the longitudinal axis defined by the body portion.
8. The identification device according to claim 2, wherein the plurality of sharpened portions are tapered in the first direction and terminate in a sharpened tip configured to pierce tissue.
9. The identification device according to claim 8, wherein the sharpened tips of the plurality of sharpened portions are disposed proximal to a distal end of the body portion.
10. The identification device according to claim 2, wherein the plurality of sharpened portions are flexible.
11. The identification device according to claim 2, wherein the body portion includes an energy source configured to emit energy selected from the group consisting of light, heat, radiation, electromagnetic, and sound.
12. An identification device, comprising:
a body portion configured to mark a location in a patient's body and defining a longitudinal axis;
a plurality of rings coupled to an outer surface of the body portion and disposed axially around the longitudinal axis defined by the body portion; and
a plurality of sharpened barbs extending distally from each of the plurality of rings parallel to the longitudinal axis defined by the body portion, the plurality of sharpened barbs configured to be inserted into tissue upon movement of the body portion in a proximal to distal direction to removably anchor the body portion to the tissue.
13. The identification device according to claim 12, wherein each of the plurality of sharpened barbs of one of the plurality of rings is collinear with a respective one of the plurality of sharpened barbs of another of the plurality of rings along the longitudinal axis defined by the body portion.
14. The identification device according to claim 12, wherein the body portion includes an energy source configured to emit energy selected from the group consisting of light, heat, radiation, electromagnetic, sound, and cryo.
15. The identification device according to claim 12, wherein the body portion extends between a closed proximal end and a closed distal end.
16. The identification device according to claim 12, wherein the plurality of sharpened barbs are evenly spaced around the longitudinal axis defined by the body portion.
17. The identification device according to claim 13, wherein the plurality of sharpened barbs are tapered in the distal direction and terminate in a sharpened tip configured to pierce tissue.
18. The identification device according to claim 13, wherein the plurality of sharpened barbs are flexible.
19. An identification device, comprising:
at least one ring having a plurality barbs extending distally therefrom; and
a body portion configured to mark a location in a patient's body, the body portion disposed axially through the at least one ring and having an outer surface coupled to an inner surface of the at least one ring, the plurality of barbs extending parallel to a longitudinal axis defined by the body portion, wherein movement of the body portion in a proximal to distal direction advances at least one of the plurality of barbs into tissue to removably anchor the body portion to the tissue.
20. The device according to claim 19, wherein the at least one ring comprises a plurality of rings longitudinally spaced from each other along the longitudinal axis defined by the body portion.
21. The device of claim 19, wherein the plurality of barbs include a sharpened distal tip disposed proximal to a distal end of the body portion.
US16/281,564 2008-01-29 2019-02-21 Target identification tool for intra-body localization Abandoned US20190183601A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/281,564 US20190183601A1 (en) 2008-01-29 2019-02-21 Target identification tool for intra-body localization

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6291408P 2008-01-29 2008-01-29
US5163208P 2008-05-08 2008-05-08
US12/362,421 US9375287B2 (en) 2008-01-29 2009-01-29 Target identification tool for intra-body localization
US15/194,667 US10238464B2 (en) 2008-01-29 2016-06-28 Target identification tool for intra-body localization
US16/281,564 US20190183601A1 (en) 2008-01-29 2019-02-21 Target identification tool for intra-body localization

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US15/194,667 Continuation US10238464B2 (en) 2008-01-29 2016-06-28 Target identification tool for intra-body localization

Publications (1)

Publication Number Publication Date
US20190183601A1 true US20190183601A1 (en) 2019-06-20

Family

ID=40913241

Family Applications (4)

Application Number Title Priority Date Filing Date
US12/362,421 Expired - Fee Related US9375287B2 (en) 2008-01-29 2009-01-29 Target identification tool for intra-body localization
US13/835,450 Abandoned US20130204128A1 (en) 2008-01-29 2013-03-15 Target identification tool for intra-body localization
US15/194,667 Active US10238464B2 (en) 2008-01-29 2016-06-28 Target identification tool for intra-body localization
US16/281,564 Abandoned US20190183601A1 (en) 2008-01-29 2019-02-21 Target identification tool for intra-body localization

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US12/362,421 Expired - Fee Related US9375287B2 (en) 2008-01-29 2009-01-29 Target identification tool for intra-body localization
US13/835,450 Abandoned US20130204128A1 (en) 2008-01-29 2013-03-15 Target identification tool for intra-body localization
US15/194,667 Active US10238464B2 (en) 2008-01-29 2016-06-28 Target identification tool for intra-body localization

Country Status (3)

Country Link
US (4) US9375287B2 (en)
EP (1) EP2240110A4 (en)
WO (1) WO2009097463A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4044952A4 (en) * 2019-10-18 2023-10-18 The Brigham and Women's Hospital, Inc. System and method for a tissue resection margin measurement device
US12023108B2 (en) 2013-09-06 2024-07-02 The Brigham And Women's Hospital, Inc. System and method for a tissue resection margin measurement device

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3492008B1 (en) 2005-09-13 2021-06-02 Veran Medical Technologies, Inc. Apparatus and method for image guided accuracy verification
US20070066881A1 (en) 2005-09-13 2007-03-22 Edwards Jerome R Apparatus and method for image guided accuracy verification
WO2009097463A1 (en) * 2008-01-29 2009-08-06 Superdimension, Ltd. Target identification tool for intra body localization
US8696549B2 (en) 2010-08-20 2014-04-15 Veran Medical Technologies, Inc. Apparatus and method for four dimensional soft tissue navigation in endoscopic applications
WO2013126659A1 (en) 2012-02-22 2013-08-29 Veran Medical Technologies, Inc. Systems, methods, and devices for four dimensional soft tissue navigation
US20150305612A1 (en) 2014-04-23 2015-10-29 Mark Hunter Apparatuses and methods for registering a real-time image feed from an imaging device to a steerable catheter
US20150305650A1 (en) 2014-04-23 2015-10-29 Mark Hunter Apparatuses and methods for endobronchial navigation to and confirmation of the location of a target tissue and percutaneous interception of the target tissue
US9867974B2 (en) * 2015-06-01 2018-01-16 Wisconsin Alumni Research Foundation Microfluidic device for multiplexed point source administration of compounds
CA3038544A1 (en) * 2016-10-25 2018-05-03 Trevi Therapeutics, Inc. Treatment of prurigo nodularis
CN106693216A (en) * 2017-02-06 2017-05-24 中国人民解放军总医院 Titanium alloy gold label implant and gold label syringe
CN106730419A (en) * 2017-02-06 2017-05-31 浙江荣诚医疗科技有限公司 A kind of cobalt alloy gold mark implant
CN106621077A (en) * 2017-02-06 2017-05-10 浙江荣诚医疗科技有限公司 Hollowed-out gold mark and gold mark location device
CN112437679B (en) * 2018-09-11 2023-02-03 朝日英达科株式会社 Intracorporeal indwelling equipment

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834757A (en) * 1987-01-22 1989-05-30 Brantigan John W Prosthetic implant
US4790329A (en) * 1987-06-12 1988-12-13 Trustees Of Beth Israel Hospital Adjustable biopsy localization device
US5904690A (en) * 1989-08-16 1999-05-18 Medtronic, Inc. Device or apparatus for manipulating matter
US5105829A (en) * 1989-11-16 1992-04-21 Fabian Carl E Surgical implement detector utilizing capacitive coupling
US5269783A (en) * 1991-05-13 1993-12-14 United States Surgical Corporation Device and method for repairing torn tissue
IL117472A0 (en) 1996-03-13 1996-07-23 Instent Israel Ltd Radiopaque stent markers
US6070589A (en) * 1997-08-01 2000-06-06 Teramed, Inc. Methods for deploying bypass graft stents
WO1999060939A1 (en) * 1998-05-28 1999-12-02 Orthosoft, Inc. Interactive computer-assisted surgical system and method thereof
US6056700A (en) * 1998-10-13 2000-05-02 Emx, Inc. Biopsy marker assembly and method of use
US6725083B1 (en) * 1999-02-02 2004-04-20 Senorx, Inc. Tissue site markers for in VIVO imaging
WO2001008717A1 (en) * 1999-08-03 2001-02-08 Smith & Nephew, Inc. Controlled release implantable devices
US7039453B2 (en) * 2000-02-08 2006-05-02 Tarun Mullick Miniature ingestible capsule
CA2408069C (en) * 2000-05-10 2005-03-29 Canica Design Inc. System and method for moving and stretching plastic tissue
CA2446993C (en) * 2000-11-20 2009-06-02 Senorx, Inc. Tissue site markers for in vivo imaging
US20030163161A1 (en) * 2001-03-12 2003-08-28 Barron John Christopher Bone anchor protective cover
US7144363B2 (en) * 2001-10-16 2006-12-05 Extensia Medical, Inc. Systems for heart treatment
US7150750B2 (en) * 2002-01-10 2006-12-19 Boston Scientific Scimed, Inc. Method and device for endoscopic suturing
US6942667B1 (en) * 2002-04-02 2005-09-13 Vanderbilt University Bone anchor
US7329414B2 (en) * 2002-05-03 2008-02-12 Biopsy Sciences, Llc Biodegradable polymer for marking tissue and sealing tracts
US7720522B2 (en) * 2003-02-25 2010-05-18 Medtronic, Inc. Fiducial marker devices, tools, and methods
US7678068B2 (en) * 2002-12-02 2010-03-16 Gi Dynamics, Inc. Atraumatic delivery devices
US7001341B2 (en) * 2003-08-13 2006-02-21 Scimed Life Systems, Inc. Marking biopsy sites
US7556647B2 (en) * 2003-10-08 2009-07-07 Arbor Surgical Technologies, Inc. Attachment device and methods of using the same
US8196589B2 (en) * 2003-12-24 2012-06-12 Calypso Medical Technologies, Inc. Implantable marker with wireless signal transmitter
GB0405013D0 (en) * 2004-03-05 2004-04-07 Depuy Int Ltd Implantable marker instruments and methods
US20050234336A1 (en) * 2004-03-26 2005-10-20 Beckman Andrew T Apparatus and method for marking tissue
US20050283190A1 (en) 2004-06-16 2005-12-22 Huitema Thomas W Surgical fastener
US20090216115A1 (en) * 2004-07-23 2009-08-27 Calypso Medical Technologies, Inc. Anchoring wirless markers within a human body
US20060173361A1 (en) * 2004-08-20 2006-08-03 Vanderbilt University Endoscopy capsule with site marking capability and application of the same
US7077800B2 (en) * 2004-09-15 2006-07-18 Ut Battelle, Llc Cable attachment for a radioactive brachytherapy source capsule
US8280486B2 (en) * 2004-10-13 2012-10-02 Suros Surgical Systems, Inc. Site marker visable under multiple modalities
EP1841502A2 (en) * 2005-01-18 2007-10-10 Koninklijke Philips Electronics N.V. Electronically controlled capsule for releasing radiation
US7758594B2 (en) * 2005-05-20 2010-07-20 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8052658B2 (en) * 2005-10-07 2011-11-08 Bard Peripheral Vascular, Inc. Drug-eluting tissue marker
US8170647B2 (en) 2006-01-20 2012-05-01 Best Medical International, Inc Fiduciary markers and method of use thereof
US8491631B2 (en) * 2006-01-30 2013-07-23 Children's Medical Center Corporation Tissue tack
US7996059B2 (en) * 2006-03-08 2011-08-09 Biosense Webster, Inc. Esophagus imaging enhancement device
US20070238979A1 (en) * 2006-03-23 2007-10-11 Medtronic Vascular, Inc. Reference Devices for Placement in Heart Structures for Visualization During Heart Valve Procedures
US7741273B2 (en) * 2006-04-13 2010-06-22 Warsaw Orthopedic, Inc. Drug depot implant designs
US8523901B2 (en) * 2007-08-14 2013-09-03 Illuminoss Medical, Inc. Apparatus and methods for attaching soft tissue to bone
WO2009097463A1 (en) 2008-01-29 2009-08-06 Superdimension, Ltd. Target identification tool for intra body localization

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12023108B2 (en) 2013-09-06 2024-07-02 The Brigham And Women's Hospital, Inc. System and method for a tissue resection margin measurement device
EP4044952A4 (en) * 2019-10-18 2023-10-18 The Brigham and Women's Hospital, Inc. System and method for a tissue resection margin measurement device

Also Published As

Publication number Publication date
US10238464B2 (en) 2019-03-26
US20160302881A1 (en) 2016-10-20
EP2240110A4 (en) 2015-07-01
US20090240140A1 (en) 2009-09-24
WO2009097463A1 (en) 2009-08-06
US20130204128A1 (en) 2013-08-08
EP2240110A1 (en) 2010-10-20
US9375287B2 (en) 2016-06-28

Similar Documents

Publication Publication Date Title
US20190183601A1 (en) Target identification tool for intra-body localization
US12016640B2 (en) Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US20190269933A1 (en) Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
EP2707079B1 (en) Devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
AU2016256761B2 (en) Target identification tool for intra-lumenal localization
US10258373B2 (en) Fiducial deployment needle system
JP5833776B2 (en) Fiducial deployment system
CN111407395B (en) Positioning system and method of use

Legal Events

Date Code Title Description
AS Assignment

Owner name: SUPERDIMENSION, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SUPERDIMENSION, LTD.;REEL/FRAME:048397/0827

Effective date: 20121008

Owner name: SUPERDIMENSION, LTD., ISRAEL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FITELZON, SHAI;HASTINGS, PAIGE B.;MCKINLEY, DAVID J.;SIGNING DATES FROM 20090129 TO 20090420;REEL/FRAME:048397/0548

Owner name: RIOJA LLC, DELAWARE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SUPERDIMENSION, INC.;REEL/FRAME:048397/0918

Effective date: 20130204

Owner name: COVIDIEN LP, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RIOJA LLC;REEL/FRAME:048397/0992

Effective date: 20130204

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION